Our partners
We partner with organizations across sectors to accelerate discovery and raise awareness of liver disease

Corporate partnerships


Cellaïon is a biotechnology company established in 2021 that develops cellular therapy using the anti-inflammatory and regenerative signaling properties of liver stem cells.


GENFIT stands as a global leader in the biotechnological sector, specializing in the discovery and development of therapeutics for liver diseases, with a particular focus on acute-on-chronic liver failure (ACLF).


Grifols S.A. is a global healthcare company founded in 1909, leader in essential plasma-derived and transfusion medicines.


Since 2022, Versantis is part of GENFIT. Versantis GmbH is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to treat rare pediatric and acute liver diseases.